Oculis Publishes Notifications of Transactions by Persons Discharging Managerial Responsibilities

Oculis (OCS) announced notifications of ordinary share purchases by a member of its Board of Directors.

Rhea-AI Summary

Oculis (OCS) announced notifications of ordinary share purchases by a member of its Board of Directors.

The company attached transaction notices dated March 12, 2026 and March 13, 2026, naming board member Christina Ackermann.

Argus Mar 16 session

+2.32% close to close Open Argus

Details

News Market Reaction – OCS

In the Mar 16 session, OCS gained 2.32%, reflecting a moderate positive market reaction.

Data tracked by StockTitan Argus on the day of publication.

Market Context

This announcement highlights a board member’s purchase of ordinary shares, signaling direct exposure...

Analysis

This announcement highlights a board member’s purchase of ordinary shares, signaling direct exposure to Oculis alongside shareholders. It follows a series of governance and disclosure events, including RSU vestings and financial statement filings. Investors may track patterns in such managerial transactions alongside previously registered resale capacity of up to 494,259 warrant-linked shares and past equity financings to understand how insider activity and potential share supply interact over time.

Key Figures

Press release date: March 16, 2026

Press release date

March 16, 2026

Notification of director share purchases publication date

Historical Context

5 past events · Latest: Mar 11

5 events

1. Mar 11

   Manager equity awards

   24h Move

   -0.7%

   Annual equity incentive awards disclosed for executive committee members.

2. Mar 06

   RSU vesting notice

   24h Move

   +1.7%

   Notifications on vesting and settlement of RSUs for multiple directors.

3. Mar 05

   2025 financial filing

   24h Move

   +0.1%

   Filing of 2025 audited IFRS financial statements and MD&A on Form 20-F.

4. Mar 05

   Investor conferences

   24h Move

   +0.1%

   Announcement of March 2026 conference participation and late-stage pipeline updates.

5. Mar 04

   RSU vesting notice

   24h Move

   +0.1%

   Disclosure of RSU vesting and settlement for director Arshad Khanani.

24h Move is the share-price change in the day after each event; other market factors may also have contributed.

Key Terms

persons discharging managerial responsibilities

1 terms

persons discharging managerial responsibilities regulatory

"Oculis Publishes Notifications of Transactions by Persons Discharging Managerial Responsibilities"

Persons Discharging Managerial Responsibilities are the key people in a company who make big decisions, like top managers or executives. Knowing who they are is important because their actions can influence the company’s success or failure, and they are often required to share information about their dealings to ensure transparency for investors and the public.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

ZUG, Switzerland, March 16, 2026 (GLOBE NEWSWIRE) -- The attached notifications relate to the purchase of ordinary shares by a member of the Company’s Board of Directors.

Attachments

• notification-of-managers-transaction-christina-ackermann-12 march 2026
• notification-of-managers-transaction-christina-ackermann-13 march 2026

FAQ

What did Oculis (OCS) announce on March 16, 2026 about insider transactions?

Oculis announced that a board member purchased ordinary shares on March 12 and March 13, 2026. According to the company, attached notifications name Christina Ackermann and serve as regulatory disclosure of managerial transactions.

Who is Christina Ackermann and what transactions did she report with OCS in March 2026?

Christina Ackermann is a member of Oculis's board who reported purchases of ordinary shares in March 2026. According to the company, notifications dated March 12 and March 13, 2026 were attached detailing those managerial transactions.

Does the board member share purchase disclosed by Oculis (OCS) imply a change in company outlook?

Insider purchases can signal confidence but do not guarantee any change in company outlook or stock performance. According to the company, these filings are disclosure items and investors should weigh broader financial and market factors.

Where can investors access the full Oculis (OCS) notifications for the March 2026 insider purchases?

Investors can access the full notifications attached to the March 16, 2026 announcement on Oculis's investor relations or regulatory filings pages. According to the company, attachments list the March 12 and March 13 transaction notices by Christina Ackermann.